Literature DB >> 24662847

The dense core vesicle protein IA-2, but not IA-2β, is required for active avoidance learning.

G N Carmona1, T Nishimura1, C W Schindler2, L V Panlilio2, A L Notkins3.   

Abstract

The islet-antigens IA-2 and IA-2β are major autoantigens in type-1 diabetes and transmembrane proteins in dense core vesicles (DCV). Recently we showed that deletion of both IA-2 and IA-2β alters the secretion of hormones and neurotransmitters and impairs behavior and learning. The present study was designed to evaluate the contribution to learning of each of these genes by using single knockout (SKO) and double knockout (DKO) mice in an active avoidance test. After 5 days of training, wild-type (WT) mice showed 60-70% active avoidance responses, whereas the DKO mice showed only 10-15% active avoidance responses. The degree of active avoidance responses in the IA-2 SKO mice was similar to that of the DKO mice, but in contrast, the IA-2β SKO mice behaved like WT mice showing 60-70% active avoidance responses. Molecular studies revealed a marked decrease in the phosphorylation of the cAMP response element-binding protein (CREB) and Ca(2+)/calmodulin-dependent protein kinase II (CAMKII) in the striatum and hippocampus of the IA-2 SKO and DKO mice, but not in the IA-2β SKO mice. To evaluate the role of CREB and CAMKII in the SKO and DKO mice, GBR-12909, which selectively blocks the dopamine uptake transporter and increases CREB and CAMKII phosphorylation, was administered. GBR-12909 restored the phosphorylation of CREB and CAMKII and increased active avoidance learning in the DKO and IA-2 SKO to near the normal levels found in the WT and IA-2β SKO mice. We conclude that in the absence of the DCV protein IA-2, active avoidance learning is impaired. Published by Elsevier Ltd.

Entities:  

Keywords:  CAMKII; CREB; autoantigens; dopamine; type-1 diabetes

Mesh:

Substances:

Year:  2014        PMID: 24662847      PMCID: PMC4038122          DOI: 10.1016/j.neuroscience.2014.03.023

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  29 in total

Review 1.  Addiction, dopamine, and the molecular mechanisms of memory.

Authors:  J D Berke; S E Hyman
Journal:  Neuron       Date:  2000-03       Impact factor: 17.173

2.  Impaired spatial learning in alpha-calcium-calmodulin kinase II mutant mice.

Authors:  A J Silva; R Paylor; J M Wehner; S Tonegawa
Journal:  Science       Date:  1992-07-10       Impact factor: 47.728

3.  Learning a new behavioral strategy in the shuttle-box increases prefrontal dopamine.

Authors:  H Stark; T Rothe; T Wagner; H Scheich
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

4.  Deletion of Ia-2 and/or Ia-2β in mice decreases insulin secretion by reducing the number of dense core vesicles.

Authors:  T Cai; H Hirai; G Zhang; M Zhang; N Takahashi; H Kasai; L S Satin; R D Leapman; A L Notkins
Journal:  Diabetologia       Date:  2011-07-06       Impact factor: 10.122

5.  Targeted disruption of the protein tyrosine phosphatase-like molecule IA-2 results in alterations in glucose tolerance tests and insulin secretion.

Authors:  Keiichi Saeki; Min Zhu; Atsutaka Kubosaki; Jingping Xie; Michael S Lan; Abner Louis Notkins
Journal:  Diabetes       Date:  2002-06       Impact factor: 9.461

6.  Calcium/calmodulin-dependent kinase II and long-term potentiation enhance synaptic transmission by the same mechanism.

Authors:  P M Lledo; G O Hjelmstad; S Mukherji; T R Soderling; R C Malenka; R A Nicoll
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

7.  Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma.

Authors:  M S Lan; J Lu; Y Goto; A L Notkins
Journal:  DNA Cell Biol       Date:  1994-05       Impact factor: 3.311

8.  Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein.

Authors:  R Bourtchuladze; B Frenguelli; J Blendy; D Cioffi; G Schutz; A J Silva
Journal:  Cell       Date:  1994-10-07       Impact factor: 41.582

9.  Targeted disruption of the IA-2beta gene causes glucose intolerance and impairs insulin secretion but does not prevent the development of diabetes in NOD mice.

Authors:  Atsutaka Kubosaki; Steffen Gross; Junnosuke Miura; Keiichi Saeki; Min Zhu; Shinichiro Nakamura; Wiljan Hendriks; Abner Louis Notkins
Journal:  Diabetes       Date:  2004-07       Impact factor: 9.461

10.  Dopamine D2L receptor knockout mice display deficits in positive and negative reinforcing properties of morphine and in avoidance learning.

Authors:  J W Smith; L A Fetsko; R Xu; Y Wang
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

View more
  5 in total

1.  The Ia-2β intronic miRNA, miR-153, is a negative regulator of insulin and dopamine secretion through its effect on the Cacna1c gene in mice.

Authors:  Huanyu Xu; Liron Abuhatzira; Gilberto N Carmona; Suryakiran Vadrevu; Leslie S Satin; Abner L Notkins
Journal:  Diabetologia       Date:  2015-07-04       Impact factor: 10.122

2.  Pathophysiologic changes in IA-2/IA-2β null mice are secondary to alterations in the secretion of hormones and neurotransmitters.

Authors:  Tao Cai; Abner L Notkins
Journal:  Acta Diabetol       Date:  2015-04-11       Impact factor: 4.280

3.  Regenerative neurogenic response from glia requires insulin-driven neuron-glia communication.

Authors:  Neale J Harrison; Elizabeth Connolly; Alicia Gascón Gubieda; Zidan Yang; Benjamin Altenhein; Maria Losada Perez; Marta Moreira; Jun Sun; Alicia Hidalgo
Journal:  Elife       Date:  2021-02-02       Impact factor: 8.140

4.  The association of genetically controlled CpG methylation (cg158269415) of protein tyrosine phosphatase, receptor type N2 (PTPRN2) with childhood obesity.

Authors:  Suman Lee
Journal:  Sci Rep       Date:  2019-03-19       Impact factor: 4.379

Review 5.  The study of active avoidance: A platform for discussion.

Authors:  Maria M Diehl; Christian Bravo-Rivera; Gregory J Quirk
Journal:  Neurosci Biobehav Rev       Date:  2019-09-08       Impact factor: 8.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.